AAAAAA

   
Results: 1-8 |
Results: 8
Gemcitabine as single-agent therapy in the management of advanced breast cancer
Authors: Seidman, AD
Citation: Ad. Seidman, Gemcitabine as single-agent therapy in the management of advanced breast cancer, ONCOLOGY-NY, 15(2), 2001, pp. 11-14
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
Authors: Seidman, AD Fornier, MN Esteva, FJ Tan, L Kaptain, S Bach, A Panageas, KS Arroyo, C Valero, V Currie, V Gilewski, T Theodoulou, M Moynahan, ME Moasser, M Sklarin, N Dickler, M D'Andrea, G Cristofanilli, M Rivera, E Hortobagyi, GN Norton, L Hudis, CA
Citation: Ad. Seidman et al., Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification, J CL ONCOL, 19(10), 2001, pp. 2587-2595
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
Authors: Van Poznak, C Seidman, AD Reidenberg, MM Moasser, MM Sklarin, N Van Zee, K Borgen, P Gollub, M Bacotti, D Yao, TJ Bloch, R Ligueros, M Sonenberg, M Norton, L Hudis, C
Citation: C. Van Poznak et al., Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial, BREAST CANC, 66(3), 2001, pp. 239-248
The evolving role of gemcitabine in the management of breast cancer
Authors: Seidman, AD
Citation: Ad. Seidman, The evolving role of gemcitabine in the management of breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 189-198
Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer
Authors: Fornier, M Esteva, FJ Seidman, AD
Citation: M. Fornier et al., Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer, SEMIN ONCOL, 27(6), 2000, pp. 38-45
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
Authors: D'Andrea, G Fennelly, D Norton, L Baselga, J Gilewski, T Hudis, C Moynahan, ME Raptis, G Sklarin, N Surbone, A Theodoulou, M Templeton, MA Yao, TJ Seidman, AD
Citation: G. D'Andrea et al., Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer, CLIN CANC R, 5(2), 1999, pp. 275-279
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
Authors: Baselga, J Tripathy, D Mendelsohn, J Baughman, S Benz, CC Dantis, L Sklarin, NT Seidman, AD Hudis, CA Moore, J Rosen, PP Twaddell, T Henderson, IC Norton, L
Citation: J. Baselga et al., Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer, SEMIN ONCOL, 26(4), 1999, pp. 78-83
Single-agent paclitaxel in the treatment of breast cancer: Phase I and II development
Authors: Seidman, AD
Citation: Ad. Seidman, Single-agent paclitaxel in the treatment of breast cancer: Phase I and II development, SEMIN ONCOL, 26(3), 1999, pp. 14-20
Risultati: 1-8 |